GT Biopharma, Inc.
GTBP
$2.38
$0.093.93%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -38.44% | -30.61% | -5.69% | -29.81% | -12.75% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -24.19% | 1,277.78% | -76.92% | -7.14% | 121.05% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | -- | -- | -- | -- |
| Total Current Assets | -37.39% | -27.06% | -6.25% | -29.67% | -12.43% |
|
|
|||||
| Total Current Assets | -37.39% | -27.06% | -6.25% | -29.67% | -12.43% |
| Net Property, Plant & Equipment | -- | -- | -- | -49.06% | -39.08% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -37.39% | -27.06% | -6.51% | -29.75% | -12.63% |
|
|
|||||
| Total Accounts Payable | 47.51% | 52.13% | -46.56% | -25.76% | 9.02% |
| Total Accrued Expenses | -3.80% | 5.84% | 83.28% | -19.41% | 16.25% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -48.28% | -36.96% |
| Total Finance Division Other Current Liabilities | 38.46% | -34.30% | -29.70% | -62.55% | -- |
| Total Other Current Liabilities | 38.46% | -34.30% | -29.70% | -62.55% | -- |
| Total Current Liabilities | 26.60% | 24.02% | -18.28% | -30.65% | 30.31% |
|
|
|||||
| Total Current Liabilities | 26.60% | 24.02% | -18.28% | -30.65% | 30.31% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 26.60% | 24.02% | -18.28% | -30.65% | 7.98% |
|
|
|||||
| Common Stock & APIC | 0.00% | 0.00% | 0.57% | 0.01% | 0.06% |
| Retained Earnings | -0.55% | -0.50% | -0.54% | -0.33% | -0.44% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -179.72% | -61.94% | 3.69% | -28.95% | -25.28% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | -179.72% | -61.94% | 3.69% | -28.95% | -25.28% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -179.64% | -61.93% | 3.69% | -28.95% | -25.28% |
|
|
|||||